Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective study

PURPOSE: In cases of non-small cell lung cancer (NSCLC), surgery remains the best option for cure, but surgery is of benefit only when the disease is localized. Although adjuvant chemotherapy reportedly has a significant beneficial effect on survival, the benefit of a carboplatin (CBDCA) regimen is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Surg Oncol
Main Authors: Takashima, Shinogu, Imai, Kazuhiro, Atari, Maiko, Matsuo, Tsubasa, Nakayama, Katsutoshi, Sato, Yusuke, Motoyama, Satoru, Shibata, Hiroyuki, Nomura, Kyoko, Minamiya, Yoshihiro
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7545843/
https://ncbi.nlm.nih.gov/pubmed/33032626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-020-02041-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados